is counsel in Dechert LLP’s New York office, and a member of the firm’s antitrust/competition practice. She advises clients on obtaining required pre-merger clearances and serves as the firm’s specialist on Hart-Scott-Rodino (HSR) Act issues and filings. Ms Ang has extensive experience in counselling clients, including private equity and other investment fund managers, as well as privately and publicly held companies, on HSR compliance in matters ranging from routine investments to transformative mergers. She has guided clients through the HSR process on numerous transactions in diverse industries, including CVS Health’s acquisition of Aetna, Court Square Capital Partners’ sale of Rocket Software to Bain Capital, Cerberus Capital Management’s sale of PaxVax Global to Emergent BioSolutions, Differential Brands Group’s acquisition of Global Brands Group’s North American business, Crown Holdings’ acquisition of Signode, and Concentra’s combination with US HealthWorks.
Chambers and Partners make no representation or endorsement of the quality and services supplied
by companies or firms that may be found on this website. In no event will Chambers and Partners
be liable for any damages including, without limitation, indirect or consequential damages,
or any damages whatsoever arising from use or loss of use, data, or profits, whether in action
of contract, negligence or other tort action, arising out of or in connection with the use
of the website.